Literature DB >> 9878860

Chronic in vivo morphine administration facilitates primed-bursts-induced long-term potentiation of Schaffer collateral-CA1 synapses in hippocampal slices in vitro.

F A Mansouri1, F Motamedi, Y Fathollahi.   

Abstract

In this study, the effects of chronic morphine administration (20-30 days) on long-term potentiation (LTP) were investigated at the Schaffer collateral-CA1 pyramidal cell synapses of the rat hippocampal slices. Orthodromic population spike (OPS) amplitude and delay (peak latency) were measured as indices of increase in synaptic efficacy. The amounts of LTP of OPS delay and LTP of OPS amplitude were higher in slices from dependent rats. Perfusion of slices from control and dependent rats with morphine containing ACSF and delivering tetanic stimulation, showed that short-term presence of morphine could not mimic the LTP enhancing effects of chronic morphine administration, however, attenuated the amount of LTP of OPS amplitude in slices of dependent rats. This study supports the hypothesis that the susceptibility of CA1 synapses to plastic changes increases by chronic, not acute exposure to morphine and suggests that a withdrawal phenomenon might be an underlying mechanism for the observed augmented LTP of OPS amplitude in slices of dependent rats. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878860     DOI: 10.1016/s0006-8993(98)01148-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

3.  Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories.

Authors:  Daniel García-Pérez; Szilamer Ferenczi; Krisztina J Kovács; M Luisa Laorden; M Victoria Milanés; Cristina Núñez
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

4.  Mu opioid receptor activation normalizes temporo-ammonic pathway driven inhibition in hippocampal CA1.

Authors:  A Rory McQuiston
Journal:  Neuropharmacology       Date:  2010-11-04       Impact factor: 5.250

5.  Layer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by mu-opioid receptor activation.

Authors:  A R McQuiston
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

6.  Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction.

Authors:  Ya Yang; Xigeng Zheng; Yongfu Wang; Jun Cao; Zhifang Dong; Jingxia Cai; Nan Sui; Lin Xu
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 7.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

8.  Effect of Aqueous Extract of Crocus sativus L. on Morphine-Induced Memory Impairment.

Authors:  Sayede Maryam Naghibi; Mahmoud Hosseini; Fatemeh Khani; Motahare Rahimi; Farzaneh Vafaee; Hassan Rakhshandeh; Azita Aghaie
Journal:  Adv Pharmacol Sci       Date:  2012-10-10

9.  Proteomic analysis of protein composition of rat hippocampus exposed to morphine for 10 days; comparison with animals after 20 days of morphine withdrawal.

Authors:  Hana Ujcikova; Kristina Cechova; Michal Jagr; Lenka Roubalova; Miroslava Vosahlikova; Petr Svoboda
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.